Free Trial

Tilray Brands (TLRY) Competitors

Tilray Brands logo
C$0.84 -0.03 (-3.45%)
As of 04:00 PM Eastern

TLRY vs. AUP, CARA, CRON, TEV, ABT, NOT, PYR, SLS, NVO, and DNA

Should you be buying Tilray Brands stock or one of its competitors? The main competitors of Tilray Brands include Aurinia Pharmaceuticals (AUP), Cara Operations (CARA), Cronos Group (CRON), Tervita (TEV), Absolute Software Co. (ABT.TO) (ABT), Noront Resources (NOT), PyroGenesis Canada Inc. (PYR.V) (PYR), Solaris Resources (SLS), Novo Resources Corp. (NVO.V) (NVO), and Dalradian Resources (DNA). These companies are all part of the "pharmaceutical products" industry.

Tilray Brands vs.

Aurinia Pharmaceuticals (TSE:AUP) and Tilray Brands (TSE:TLRY) are both computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their community ranking, media sentiment, earnings, dividends, valuation, institutional ownership, profitability, risk and analyst recommendations.

Tilray Brands has higher revenue and earnings than Aurinia Pharmaceuticals. Tilray Brands is trading at a lower price-to-earnings ratio than Aurinia Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurinia PharmaceuticalsC$57.59M0.00-C$190.03M-C$1.48N/A
Tilray BrandsC$610.34M0.87-C$183.24M-C$0.41-1.98

In the previous week, Tilray Brands had 3 more articles in the media than Aurinia Pharmaceuticals. MarketBeat recorded 3 mentions for Tilray Brands and 0 mentions for Aurinia Pharmaceuticals. Tilray Brands' average media sentiment score of 0.60 beat Aurinia Pharmaceuticals' score of 0.00 indicating that Tilray Brands is being referred to more favorably in the news media.

Company Overall Sentiment
Aurinia Pharmaceuticals Neutral
Tilray Brands Positive

Aurinia Pharmaceuticals received 247 more outperform votes than Tilray Brands when rated by MarketBeat users. Likewise, 72.22% of users gave Aurinia Pharmaceuticals an outperform vote while only 0.00% of users gave Tilray Brands an outperform vote.

CompanyUnderperformOutperform
Aurinia PharmaceuticalsOutperform Votes
247
72.22%
Underperform Votes
95
27.78%
Tilray BrandsOutperform Votes
No Votes
Underperform Votes
7
100.00%

11.2% of Tilray Brands shares are owned by institutional investors. 0.7% of Tilray Brands shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Aurinia Pharmaceuticals has a net margin of 0.00% compared to Tilray Brands' net margin of -30.02%. Aurinia Pharmaceuticals' return on equity of 0.00% beat Tilray Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Aurinia PharmaceuticalsN/A N/A N/A
Tilray Brands -30.02%-7.24%-1.41%

Summary

Tilray Brands beats Aurinia Pharmaceuticals on 8 of the 13 factors compared between the two stocks.

Remove Ads
Get Tilray Brands News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLRY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLRY vs. The Competition

MetricTilray BrandsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$528.38MC$2.20BC$5.40BC$5.39B
Dividend YieldN/A2.92%4.87%6.44%
P/E Ratio-1.984.2722.8829.71
Price / Sales0.87471.99357.30524.25
Price / Cash5.9510.2538.1683.21
Price / Book0.216.196.323.35
Net Income-C$183.24MC$20.70BC$3.21BC$300.28M
7 Day Performance-13.68%-2.00%-6.89%-5.05%
1 Month Performance-18.00%-4.07%-1.87%-3.05%
1 Year Performance-77.35%89.60%4.62%7.64%

Tilray Brands Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLRY
Tilray Brands
N/AC$0.84
-3.4%
N/A-77.3%C$541.27MC$610.34M-2.032,650Gap Down
AUP
Aurinia Pharmaceuticals
N/AN/AN/AN/AC$2.15BC$57.59M-11.32300High Trading Volume
CARA
Cara Operations
N/AN/AN/AN/AC$1.62BN/A0.0080
CRON
Cronos Group
N/AC$2.59
+1.2%
C$3.54
+36.7%
-35.7%C$683.93MC$76.86M-14.41450
TEV
Tervita
N/AN/AN/AN/AC$672.00MC$1.36B-645.5636,800Gap Up
ABT
Absolute Software Co. (ABT.TO)
N/AN/AN/AN/AC$636.46MC$104.67M63.42115,000High Trading Volume
NOT
Noront Resources
N/AC$1.10
-0.5%
N/A+0.0%C$612.18MN/A-7.20101,700
PYR
PyroGenesis Canada Inc. (PYR.V)
N/AC$3.85
+11.0%
N/A+0.0%C$606.96MC$6.01M-154.0090Gap Up
SLS
Solaris Resources
1.7881 of 5 stars
C$4.84
-0.6%
C$13.50
+178.9%
-6.8%C$555.22MN/A-8.4310Analyst Forecast
News Coverage
NVO
Novo Resources Corp. (NVO.V)
N/AC$2.38
-0.4%
N/A+0.0%C$548.24MN/A-21.2554,400
DNA
Dalradian Resources
N/AN/AN/AN/AC$519.02MN/A-56.15640
Remove Ads

Related Companies and Tools


This page (TSE:TLRY) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners